SKYE

NASDAQStock

Skye Bioscience, Inc.

$0.65-0.05 (-7.69%)

52-Week Range

$0.71

$4.75

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

2.86

Volume

254.0K

Avg Volume

1.5M

Performance

-1.94%

-34.54%

-82.63%

YTD

-19.49%

-71.72%

-94.43%

Price Chart

ETF Exposure

SKYE is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.00%	50,532	$36K	$1.27B	0.60%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	27	$37	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	986	$1K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	4	$6	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	561,832	$567K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	2,955	$4K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	254	$348	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	184,978	$187K	$84.10B	0.05%

About SKYE ETF Exposure

Skye Bioscience, Inc. (SKYE) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $0.65. Investors can gain exposure to SKYE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold SKYE, sorted by portfolio weight.